BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22159602)

  • 1. Interactions between CD44 protein and hyaluronan: insights from the computational study.
    Plazinski W; Knys-Dzieciuch A
    Mol Biosyst; 2012 Feb; 8(2):543-7. PubMed ID: 22159602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of binding site conformational switching in the CD44-hyaluronan protein-carbohydrate binding interaction.
    Jamison FW; Foster TJ; Barker JA; Hills RD; Guvench O
    J Mol Biol; 2011 Mar; 406(4):631-47. PubMed ID: 21216252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational flexibility of a protein-carbohydrate complex and the structure and ordering of surrounding water.
    Jana M; Bandyopadhyay S
    Phys Chem Chem Phys; 2012 May; 14(18):6628-38. PubMed ID: 22460826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM; Lesley JF; Hyman R
    Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD44 cytoplasmic domain in hyaluronan binding.
    Perschl A; Lesley J; English N; Trowbridge I; Hyman R
    Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
    Lesley J; Kincade PW; Hyman R
    Eur J Immunol; 1993 Aug; 23(8):1902-9. PubMed ID: 7688309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli.
    Banerji S; Day AJ; Kahmann JD; Jackson DG
    Protein Expr Purif; 1998 Dec; 14(3):371-81. PubMed ID: 9882571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
    Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
    Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
    Mizrahy S; Raz SR; Hasgaard M; Liu H; Soffer-Tsur N; Cohen K; Dvash R; Landsman-Milo D; Bremer MG; Moghimi SM; Peer D
    J Control Release; 2011 Dec; 156(2):231-8. PubMed ID: 21745506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
    Liao HX; Lee DM; Levesque MC; Haynes BF
    J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases.
    Gee K; Kryworuchko M; Kumar A
    Arch Immunol Ther Exp (Warsz); 2004; 52(1):13-26. PubMed ID: 15053229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.
    Bourguignon LY; Gilad E; Peyrollier K; Brightman A; Swanson RA
    J Neurochem; 2007 May; 101(4):1002-17. PubMed ID: 17403031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
    Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
    J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
    Turley EA; Austen L; Moore D; Hoare K
    Exp Cell Res; 1993 Aug; 207(2):277-82. PubMed ID: 7688314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan: the local solution conformation determined by NMR and computer modeling is close to a contracted left-handed 4-fold helix.
    Almond A; Deangelis PL; Blundell CD
    J Mol Biol; 2006 May; 358(5):1256-69. PubMed ID: 16584748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.
    Das P; Li J; Royyuru AK; Zhou R
    J Comput Chem; 2009 Aug; 30(11):1654-63. PubMed ID: 19399777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.
    Levesque MC; Haynes BF
    J Immunol; 1996 Feb; 156(4):1557-65. PubMed ID: 8568260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-state conformations in the hyaluronan-binding domain regulate CD44 adhesiveness under flow condition.
    Ogino S; Nishida N; Umemoto R; Suzuki M; Takeda M; Terasawa H; Kitayama J; Matsumoto M; Hayasaka H; Miyasaka M; Shimada I
    Structure; 2010 May; 18(5):649-56. PubMed ID: 20462498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain.
    Liu D; Sy MS
    J Immunol; 1997 Sep; 159(6):2702-11. PubMed ID: 9300690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.